Gene Silencing of TGFβRII Can Inhibit Glioblastoma Cell Growth

OBJECTIVE: Glioblastoma (GBM) is the most malignant and aggressive type of glioma, associated with a high rate of mortality. The transforming growth factor-β receptor II (TGFβ RII) is involved in glioma initiation and progression. On the other hand, TGFβ RII silencing is critical to the inhibition o...

Descripción completa

Detalles Bibliográficos
Autores principales: Aval, Farzane Ordoni, Amiri, Shaghayegh Askarian, Azadmehr, Abbas, Oladnabi, Morteza, Saadat, Payam, Ebrahimi, Hadi, Baradaran, Behzad, Mansoori, Behzad, Pourabdolhossein, Fereshteh, Torabian, Pedram, Hajiahmadi, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249455/
https://www.ncbi.nlm.nih.gov/pubmed/30256570
http://dx.doi.org/10.22034/APJCP.2018.19.9.2681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249455/
https://www.ncbi.nlm.nih.gov/pubmed/30256570
http://dx.doi.org/10.22034/APJCP.2018.19.9.2681

Ejemplares similares